Springtide rallies $18.1m Series A

Connecticut and New York City-based Springtide, a practice treating children with autism spectrum disorder and developmental delays and disabilities, has secured $18.1 million in Series A financing.

Connecticut and New York City-based Springtide, a practice treating children with autism spectrum disorder and developmental delays and disabilities, has secured $18.1 million in Series A financing. Deerfield Management Company and Optum Ventures led the round.

Source: Press Release